A clinical research consortium sponsored by NIAID and JDRF
 

Accessibility Statement

The Immune Tolerance Network and its sponsors are committed to
providing access to our web pages for individuals with disabilities. To
meet this commitment, this site complies with the requirements of
Section 508 of the Rehabilitation Act.

Section 508 requires that
individuals with disabilities, who are members of the public seeking
information or services from us, have access to and use of information
and data that is comparable to that provided to the public who are not
individuals with disabilities, unless an undue burden would be imposed
on us. Section 508 also requires us to ensure that Federal employees
with disabilities have access to and use of information and data that
is comparable to the access to and use of information and data by
Federal employees who are not individuals with disabilities, unless an
undue burden would be imposed on us.

At this time, all information on immunetolerance.org should be accessible via screen
readers and other accessibility tools. If you use assistive technology
(such as a Braille reader, a screen reader, TTY, etc.) and the format
of any material on our web site interferes with your ability to access
the information, please contact our webmaster
for assistance. To enable us to respond in a manner most helpful to
you, please indicate the nature of your accessibility problem, the
preferred format in which you wish to receive the material, the web
address of the requested material, and your contact information.